… and clinical considerations for patients on biologic agents (biologicals) targeting the type
2 inflammatory response due to difficult-to-treat allergic diseases in the context of COVID-19. …

… coronavirus-2019 (COVID-19) infection pandemic has affected the care of patients with heart
failure (HF) who have contracted COVID-19 as well as those without COVID-19 … , COVID-19 …

… and clinical evidence to support the benefit of the influenza, pneumococcal, and tuberculosis
vaccines in the context of COVID-19 as well as to provide an overview on the COVID-19-…

… respiratory function from COVID-19-associated pneumonia or … as COVID-19 and the paucity
of literature on this aspect, this narrative review aims to explore the practical considerations …

… sex and/or gender in COVID-19 studies on ClinicalTrials.gov, … 4,420 registered SARS-CoV-2/COVID-19
studies, 935 (21.2%) … Just eight (17.8%) of the 45 COVID-19 related clinical trials …

… coronavirus 2 (SARS-CoV-2) was responsible for over 85 million cases of coronavirus disease
2019 (COVID-19) … higher risk of severe manifestations from COVID-19 compared with non-…

… coronavirus 2 (SARS-CoV-2), there are insufficient clinical data to … with severe COVID-19
infection, awaiting further clinical trials. … workers against most clinical exposures to COVID-19. …

… the CV impact of COVID-19, its potential consequences in patients with established CVD,
as well as considerations for individual patients (with and without COVID-19), health care …

… clinical trials aimed at evaluating the therapeutic efficacy of angiotensin receptor blocker (ARB)
use in COVID-19… to the time of diagnosis of COVID-19 as well as the administered doses. …

… and includes considerations related to dental treatment in both healthy subjects and those
suspected or diagnosed with COVID-19. Operatory and clinical considerations are discussed, …